The virtual ERS International Congress will take place from 7–9 September, 2020.Aerogen are running a lunchtime symposium on Monday September 7th entitled Aerosol Therapy in Pulmonary and Critical Care from 13.15 – 14.15 CET.
Join leading critical care experts for a discussion regarding aerosol drug delivery to patients receiving both ventilatory and non-ventilatory support in the era of COVID-19 and how to implement best practices for optimal patient care.
CHAIRMAN’S WELCOME AND INTRODUCTIONProfessor Antonio Artigas, MD, PhD
AEROSOL DRUG DELIVERY IN THE VENTILATED PATIENTProfessor Julien Pottecher, MD, PhD
AEROSOL DRUG DELIVERY IN THE NON-VENTILATED PATIENTDr Sundeep Kaul, MD, PhD
Q & A AND CONCLUDING REMARKS
About ERS CongressWelcoming over 20,000 delegates every year, the annual ERS Congress is a showcase of excellence across the entire field of respiratory medicine.
The ERS Congress programme is made up of a wide variety of sessions types, all designed to ensure that information is presented in the most effective way. ERS will be bringing back many of the most popular sessions for this year’s Congress, aided by a specially designed virtual platform.
About AerogenFounded in Galway, Ireland in 1997, Aerogen now employs over 200 people worldwide and its products have benefited over 7 million patients. The company, synonymous with scientific excellence, and with a wealth of international awards, has a strong international presence with offices in Ireland, UK, Germany, United States, Middle East, Asia and most recently India.
Aerogen specialises in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of patients, enhancing outcomes and giving healthcare professionals a higher level of confidence and control.